{"schema_version":"secwatch.filing_event.v1","accession":"0001606757-26-000030","form_type":"8-K","ticker":"KE","cik":"0001606757","company_name":"Kimball Electronics, Inc.","filed_at":"2026-08-12T20:44:05+00:00","discovered_at":"2026-08-12T20:45:00.386714+00:00","generated_at":"2026-08-12T20:45:07.183177+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Kimball Electronics Q4 sales $371.6M; FY27 guidance 7-9% growth with Helvoet accretive","bullets":["Q4 net sales $371.6M (+5% seq); operating income $29.1M (7.8% of sales); adjusted op margin 4.9%.","Debt $116.6M (lowest in 4+ yrs); cash $88.9M; borrowing capacity $322.4M; operating cash $42.4M.","Q4 medical sales +1% YoY, automotive -3%, industrial -5%; cash conversion days 82 (best in 17 qtrs).","FY26 net sales $1,431.4M, medical +>10% normalized; adj op margin 4.6%; repurchased $11.9M shares.","FY27 guidance: net sales $1,535-1,560M (+7-9%), organic growth 3-5%, Helvoet ~$60M, adj op margin 4.4-4.7%."],"urls":{"canonical":"https://secwatch.observer/filing/0001606757-26-000030","json":"https://secwatch.observer/filing/0001606757-26-000030.json","markdown":"https://secwatch.observer/filing/0001606757-26-000030.md","text":"https://secwatch.observer/filing/0001606757-26-000030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1606757/000160675726000030/0001606757-26-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1606757/000160675726000030/ke-20260812.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-12T20:45:07.183177+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}